Jakob Dupont
InvestorExecutive Partner, Private Equity at Sofinnova Ventures · Board director at Apexigen
Boston, Massachusetts, United States
Find your path to Jakob
422 people in our graph share verified history with Jakob — schools, employers, funds. One of them is your warm intro.
Mira ChaurushiyaunlockedJakob: together at Genentech (2011–2016)
×3Jakob: together at Roche
×4Jakob: together at Joan & Sanford I. Weill Medical College of Cornell University
×2Jakob: together at Vassar College
About
Jakob Dupont is a physician with over two decades of experience in oncology and other therapeutic areas, focused on developing therapies for high unmet medical needs. Before joining Sofinnova in 2023, he held senior R&D and medical leadership roles at Atara Biotherapeutics, Gossamer Bio, Genentech/Roche, and OncoMed Pharmaceuticals. He earned his M.D. from Cornell University's Weill Medical College and an M.A. in philosophy from New York University, and completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Apexigen
Intro paths
→
In turn, Jakob can intro founders to Apexigen's investors below.
Apexigen's investors · 6
Co-founders at Apexigen
XY
Xiaodong YangPresident, CEO and Secretary
Experience
- Sofinnova InvestmentsExecutive Partnercurrent2023 — presentMenlo Park, California, United States
- OnCusp TherapeuticsBoard Observercurrent2025 — presentNew York, New York, United States
- Bolt Biotherapeutics, Inc.Member Board of Directorscurrent2024 — presentRedwood City, California, United States
- Avenzo TherapeuticsMember Board of Directorscurrent2024 — presentSan Diego Metropolitan Area
- Pyxis OncologyMember Board of Directorscurrent2023 — presentBoston, MA
- Imugene LimitedNon Executive Directorcurrent2022 — presentSydney, New South Wales, Australia
- Pioneering MedicinesScientific Advisory Boardcurrent2023 — presentBoston, Massachusetts, United States
- VC UniversityMentorcurrent2025 — present
- The University of Texas Medical BranchAdvisory Board Membercurrent2025 — presentGalveston, Texas, United States
- AmbrxScientific Advisory Board2021 — 2024San Diego, California, United States
- Atara BiotherapeuticsConsultant2023
- Atara BiotherapeuticsGlobal Head of Research & Development and EVP2020 — 2023South San Francisco, California, United States
- ApexigenIndependent Director2020 — 2023San Carlos, California, United States
- Gossamer BioConsultant Oncologist2020 — 2021San Diego, California, United States
- Gossamer BioChief Medical Officer2018 — 2020San Diego, California
- GenentechVice President, Global Head Breast and Gynecologic Cancer Development2017 — 2018South San Francisco, California
- Stanford University School of MedicineAdjunct Clinical Faculty: Medical Oncology2009 — 2018Stanford, California, USA
- OncoMed PharmaceuticalsChief Medical Officer and SVP2011 — 2016Redwood City, California, USA
- RocheGlobal Medical Director, Avastin2011Basel Area, Switzerland
- GenentechDirector: Early and Late Stage Development2006 — 2010South San Francisco, California, USA
- Memorial Sloan Kettering Cancer CenterResearcher: Tumor Immunology2006Human Oncology and Pathogenesis Program (HOPP)
- Memorial Sloan Kettering Cancer CenterResearcher: The Laboratory of Bone Marrow Transplantation (PI: Richard O'Reilly)2002 — 2006
- Memorial Sloan Kettering Cancer CenterAssistant Member2001 — 2006
- Memorial Sloan Kettering Cancer CenterResearch Fellow: The Laboratory of Gene Transfer and Gene Expression (PI: Michel Sadelain)2000 — 2002The Laboratory of Gene Transfer and Gene Expression (PI: Michel Sadelain)
- Weill Cornell Medical CollegeAssistant Professor2001 — 2006
Skills & more
CTMS1Oncology99Clinical Development99Biotechnology52Clinical Trials91Cancer73Clinical Research99Drug Development59Biomarkers6Molecular Biology5Biopharmaceuticals5Lifesciences8
+10 more
Drug DiscoveryMedical AffairsPharmaceutical IndustryGCPImmunologyHematologyMedical WritingInfectious DiseasesMedicinePharmacovigilanceLanguages Danish · English · French (some) · German (some)
- Medical Oncology — American Board of Internal Medicine
- Internal Medicine — American Board of Internal Medicine
From Jakob's professional profile.
Investments
Board seats
AvenzoBolt (BOLT)OnCusp
Per the firm's website.
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures
Frequently asked questions
- Who is Jakob Dupont?
- Jakob Dupont is a physician with over two decades of experience in oncology and other therapeutic areas, focused on developing therapies for high unmet medical needs. Before joining Sofinnova in 2023, he held senior R&D and medical leadership roles at Atara Biotherapeutics, Gossamer Bio, Genentech/Roche, and OncoMed Pharmaceuticals. He earned his M.D. from Cornell University's Weill Medical College and an M.A. in philosophy from New York University, and completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.
- Where does Jakob Dupont work?
- Jakob Dupont is Executive Partner, Private Equity at Sofinnova Ventures and Board director at Apexigen.
- What does Jakob Dupont invest in?
- Jakob Dupont invests in Biotech.
- What boards does Jakob Dupont sit on?
- Jakob Dupont holds tracked board seats at Avenzo, Bolt (BOLT), OnCusp.
- Where did Jakob Dupont go to school?
- Jakob Dupont studied at Memorial Sloan Kettering Cancer Center (Fellowship, Medical Oncology); Joan & Sanford I. Weill Medical College of Cornell University (Residency, Internal Medicine); University of Michigan Medical School (Internship, Internal Medicine).
Same school
Also attended Joan & Sanford I. Weill Medical College of Cornell University28
David KaufmanInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesKonstantinos AprilakisPartner at Deerfield Management CompanyNida ShekhaniDeputy COO & Chief Strategy Officer at Oncology VenturesTara BishopInvestor at Black Opal Ventures
+ 22 more
Also attended University of Michigan Medical School21
Ehsan SadriInvestor at Visionary VenturesAlice ZhengPartner at Foreground CapitalJordan SilvaCampus Lead at The MBA FundAlbert TzeelT1D Moonshot Impact Board at StartUp HealthEmily LeeCo-Founder & Chief Medical Officer, Wavelet at Aegis VenturesChristy LaneVenture Partner at IA Capital Group
+ 15 more
Also attended Columbia University1,304
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 1,298 more
Also attended Vassar College60
Hunter WalkCo-founder & Partner at HomebrewKevin SilverInvestment Operations Specialist at Golden SeedsJillian ShawVenture Partner at Magnetic VenturesVikram LakhwaraInvestor at Green Cow Venture CapitalCandace JohnsonSSIT Investment Committee at Seraphim SpaceWenyi HuangExecutive Director, Group Operations at The Spartan Group
)
+ 54 more
Shared employers
Also worked at Bolt Biotherapeutics, Inc.2
Also worked at The University of Texas Medical Branch5
Also worked at Gossamer Bio4
Also worked at Genentech247
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 241 more